Intravenous Iron: Evaluation of the Use of Saccharated Iron Oxide in Iron Deficiency States in Obstetrics and Gynecology

Holly, Roy G.

doi:10.1182/blood.v6.11.1159.1159

Cited by 18 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…iron to treat IDA in pregnant women was first examined almost 60 years ago; enhanced Hb levels following i.v. iron sucrose administration were demonstrated while iron not utilized by the hematopoietic tissues helped replenish maternal iron stores [17]. More recent studies have demonstrated i.v.…”

Section: IV Ironmentioning

confidence: 99%

Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region

Breymann

Bian

Blanco-Capito

et al. 2011

Journal of Perinatal Medicine

View full text Add to dashboard Cite

Anemia during pregnancy and the postpartum period is commonly caused by iron deficiency and is a significant worldwide issue with severe consequences for both mother and developing fetus. From a worldwide perspective, iron-deficiency anemia (IDA) during pregnancy is highest in the Asia-Pacific region; however, there has been little guidance in this region for safe and effective treatment. An expert panel was convened to develop a concise and informative set of recommendations for the treatment of IDA in pregnant and postpartum women in the Asia-Pacific region. This manuscript provides these recommendations and aims to reduce the morbidity and mortality associated with IDA in pregnant and postpartum women in the Asia-Pacific region. The consensus recommendations define anemia as a hemoglobin (Hb) level -10.5 g/dL during pregnancy and -10 g/dL during the postpartum period, and provide cut-off Hb levels to

show abstract

Section: IV Ironmentioning

confidence: 99%